Jeffery Cauble CPA is the CFO, Principal Financial & Accounting Officer and Corp. Sec. at ThermoGenesis Inc.
As the CFO、 Principal Financial & Accounting Officer and Corp. Sec. of ThermoGenesis Inc, the total compensation of Mr CPA at ThermoGenesis Inc is 244,000$. There are 2 executives at ThermoGenesis Inc getting paid more, with Dr. Xiaochun Xu M.B.A., Ph.D. having the highest compensation of 781,000$.
Mr CPA is 48, he's been the CFO、 Principal Financial & Accounting Officer and Corp. Sec. of ThermoGenesis Inc since . There are 8 older and 2 younger executives at ThermoGenesis Inc. The oldest executive at ThermoGenesis Holdings Inc is Philip H. Coelho, 77, who is the Chief Technology Officer.
Jeffery's mailing address filed with the SEC is 2711, Citrus Road, Rancho Cordova, Sacramento County, California, 95742, United States of America.
Over the last 5 years, insiders at ThermoGenesis Inc have traded over 612,000$ worth of ThermoGenesis Inc stock. The most active insiders traders include Xiaochun Boyalife Group, In...、Thomis Joseph. On average, ThermoGenesis Inc executives and independent directors trade stock every 0 days with the average trade being worth of 120,000$. The most recent stock trade was executed by Xiaochun Boyalife Group, In... on 17 November 2023, trading 600,000 units of THMO stock currently worth 612,000$.
thermogenesis holdings, inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (car)-t and other cell-based therapies. it markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed car-txpress platform, which streamlines the manufacturing process for the emerging car-t immunotherapy market. the company operates through two segments, device and clinical development. it manufactures and markets products for clinical bio-banking applications, including axp automated cell separation system, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and bioarchive automated cryopreservation system, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical appli
ThermoGenesis Inc executives and other stock owners filed with the SEC include: